Filana Therapeutics, Inc. (FLNA)
NASDAQ: FLNA · Real-Time Price · USD
0.4977
+0.0154 (3.19%)
Nov 11, 2026, 12:11 PM EST - Market open
Filana Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 46.99 | 95.5 | 128.57 | 121.14 | 201.02 | 233.44 |
Cash & Short-Term Investments | 46.99 | 95.5 | 128.57 | 121.14 | 201.02 | 233.44 |
Cash Growth | -55.70% | -25.72% | 6.14% | -39.74% | -13.89% | 149.65% |
Other Receivables | - | 0.12 | 0.95 | 0.96 | - | - |
Receivables | - | 0.12 | 0.95 | 0.96 | - | - |
Prepaid Expenses | 1.82 | 0.49 | 0.8 | 0.76 | 0.87 | 0.66 |
Other Current Assets | - | 1.59 | 6.21 | 6.78 | 9.34 | 10.38 |
Total Current Assets | 80.06 | 97.71 | 136.53 | 129.63 | 211.23 | 244.48 |
Property, Plant & Equipment | 20 | 20.45 | 20.96 | 21.85 | 22.99 | 20.83 |
Other Intangible Assets | - | 0.19 | 0.04 | 0.18 | 0.62 | 1.08 |
Other Long-Term Assets | - | - | - | - | - | 0.4 |
Total Assets | 100.06 | 118.36 | 157.53 | 151.66 | 234.83 | 266.78 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 40.77 | 10.4 | 6.65 | 10.57 | 4.02 | 7.13 |
Accrued Expenses | 1.02 | 2.17 | 4.05 | 3.58 | 2.45 | 4.68 |
Current Portion of Leases | - | - | - | - | 0.1 | 0.1 |
Other Current Liabilities | 0.16 | 31.27 | 1.05 | 0.05 | 0.49 | 0.63 |
Total Current Liabilities | 41.95 | 43.83 | 11.75 | 14.2 | 7.06 | 12.53 |
Long-Term Leases | - | - | - | - | 0.04 | 0.14 |
Other Long-Term Liabilities | 0.14 | 0.12 | 0.08 | - | 0.2 | 0.19 |
Total Liabilities | 42.08 | 43.95 | 11.83 | 14.2 | 7.3 | 12.87 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.05 | 0.05 | 0.05 | 0.04 | 0.04 | 0.04 |
Additional Paid-In Capital | 583.67 | 570.44 | 550.77 | 518.2 | 511.05 | 461.18 |
Retained Earnings | -525.74 | -496.08 | -405.11 | -380.77 | -283.55 | -207.31 |
Shareholders' Equity | 57.98 | 74.4 | 145.7 | 137.47 | 227.54 | 253.92 |
Total Liabilities & Equity | 100.06 | 118.36 | 157.53 | 151.66 | 234.83 | 266.78 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | - | - | - | - | 0.14 | 0.24 |
Net Cash (Debt) | 46.99 | 95.5 | 128.57 | 121.14 | 200.88 | 233.2 |
Net Cash Growth | -55.70% | -25.72% | 6.14% | -39.70% | -13.86% | 150.18% |
Net Cash Per Share | 0.97 | 1.98 | 2.76 | 2.89 | 5.00 | 5.92 |
Filing Date Shares Outstanding | 50.27 | 48.31 | 48.31 | 43.23 | 41.74 | 40.02 |
Total Common Shares Outstanding | 50.07 | 48.31 | 48.2 | 42.24 | 41.74 | 40.02 |
Working Capital | 38.11 | 53.88 | 124.78 | 115.44 | 204.16 | 231.95 |
Book Value Per Share | 1.16 | 1.54 | 3.02 | 3.25 | 5.45 | 6.35 |
Tangible Book Value | 57.98 | 74.21 | 145.67 | 137.29 | 226.92 | 252.84 |
Tangible Book Value Per Share | 1.16 | 1.54 | 3.02 | 3.25 | 5.44 | 6.32 |
Land | - | 3.73 | 3.73 | 3.73 | 3.73 | 3.73 |
Buildings | - | 15.98 | 15.98 | 15.98 | 15.98 | 15.98 |
Machinery | - | 0.89 | 0.88 | 0.87 | 0.85 | 0.18 |
Construction In Progress | - | 0.03 | 0.06 | - | 0.01 | 0.08 |
Leasehold Improvements | - | 3.47 | 3.06 | 3.06 | 3.02 | 0.57 |